2nd Annual MarketsandMarkets

Single Cell-Omics Conference

9th - 10th October 2023

Ibis London Earls Court Hotel & ILEC Conference Centre

Scrutinizing the Innovative Research in Single-Cell Omics

The fundamentals of Single Cell have proven to be an indispensable resource in the sphere of medical research and new diagnostic strategies. Recent advances in single cell technologies have opened new opportunities to signify the intra-tumor cell heterogeneity, identify rare cell kinds, degree of mutation, and ultimately guide diagnosis and treatment option.

Omics technologies helps in comprehensive examination of genome biology (Genomics), proteins (Proteomics) and RNA molecules (Transcriptomics) which in turn are used for drug discovery and development. Thus, these single cell omics prospects are much anticipated to revolutionise our adequacy to understand the magnitude of omics diversity occurring in our biological systems.

MarketsandMarkets is delighted to announce its 2nd Annual Single-Cell Omics Conference scheduled to be held on 9th – 10th October 2023 at Ibis London Earls Court Hotel & ILEC Conference Centre. The conference will assimilate diverse sessions on a board prospective of novel research and development in the field of multi-omics research. The event encompasses the Researchers, Scientists from top universities and pharmaceutical companies from all around the globe and provides the platform to share the knowledge with academic peers and present their research papers and reports.

WHAT TO EXPECT

  • Single cell genomic analysis for cancer/cellular heterogeneity
  • Single Cell Transcriptional Profiling, Digital spatial profiling
  • Spatial Single cell genome analysis – Sequencing application
  • Single-Cell phenotyping
  • Application of multiplex imaging – Single cell and tissue imaging
  • Current & Emerging Tools and Data Analysis in Single Cell Omics
  • Single Cell Analysis in Drug Discovery & Development – Sample Preparation and Processing
  • Microfluidics Tools for Single Cell Analysis
  • Cancer Biomarker discovery
  • Nanopore Technology – A Potential Application in Functional Genomics

  • Industry: Pharma/Therapeutic Companies/Start Up’s
  • CEOs, CMO’s, CSO’s, COO’s, Presidents, Vice Presidents, Directors, Managing Directors, Head of Departments, Executive Leaders, Pharmacists, Oncologists, Geneticists, Bioinformatician, Protein Scientist, Principal Scientists, Big Data Scientists, Business Development, Regulatory and Policy Advisors, Diagnostic Laboratory Professionals, Global Leaders
  • Departments: Genomics, Proteomics, Oncology, Molecular Biology, Genetics Bioinformatics, Computational Biology, Protein science, Pharmacogenomics, Biotechnology, Data Science, Microbiologists, Virologists, Pathologists
  • Academics: Universities, Research Institutes, Hospitals
  • Head of Departments, Professors, Lecturers, Senior Scientists, Researchers, Bioinformaticians
  • Departments: Genomics, Proteomics, Oncology, Molecular Biology, Genetics Bioinformatics, Computational Biology, Protein science, Pharmacogenomics, Biotechnology, Data science, Microbiologists, Virologists, Pathologists

  • Witness live action how Single-Cell Omics technology is revolutionizing the future of Biomedical research
  • Quality insights and cohesiveness of key issues with respect to Single-Cell to be addressed
  • Discover the different avenues in application of Multi-Omics studies
  • Comprehend the current and future research avenues of Single-Cell Omics in drug discovery and development
  • Discuss the emerging technologies and opportunities with cutting edge strategies
  • Opportunity for one-on-one networking with the delegates and extend professional competency

CONFERENCE AGENDA

Registration

08:15 - 08:50

Welcome note by MarketsandMarkets

08:50 - 08:55

Opening remarks by the Chairperson

08:55 - 09:00

Novel Research in Single-Cell Omics Analysis

Single cell genomic analysis for cancer/cellular heterogeneity

09:00 - 09:30

Current Landscape of Liquid Biopsies as a Tool for Cancer Diagnosis and Prognosis

Emmanouil Karteris

Emmanouil Karteris, Reader in Biomedical Sciences, Brunel University

09:30 - 10:00

Namocell, Low Pressure Single Cell Dispensing to Improve Cell Viability

Steven Johnstone

Steven Johnstone, Field Applications Scientist, EMEA FAS, Bio-Techne

10:00 - 10:30

Morning Refreshments and Poster Presentation | One-to-One Networking Meeting

10:30 - 11:20

Deconvoluting Genetic and Transcriptomic Tumour Heterogeneity Underlying Aggressive ER+ Breast Cancers

Shefali Thakur

Shefali Thakur, Higher Scientific Officer, The Institute of Cancer Research

11:20 - 11:50

Multiplexing high-throughput proteomics analysis

11:50 - 12:20

WOLF Microfluidic Sorting Preserves Cell Health, Stemness and Viability

Michal Bonar

Michal Bonar, Distribution Support Manager EMEA, Nanocellect

12:20 - 12:50

Leveraging Multiomics Data to better understand Mechanisms of Resistance to Therapy and Develop Cancer Biomarkers.

Danish Memon

Danish Memon, Lead Bioinformatics Scientist, ThirtyFiveBio

12:50 - 13:20

Lunch and Poster Presentation | One-to-One Networking

13:20 - 14:20

Single-Cell Sequencing in Rare Diseases and our Research is now more focusing on Therapeutics of Rare Diseases: Using Autologous Stem Cell Therapy in the Area of Muscle Diseases, Cancer, and Aging Related Diseases.

Rick Kamps

Rick Kamps, Head Research Engineer in the Department of Toxicogenomics, Maastricht University

14:20 - 14:50

Proteomics Data Analysis at the Single Cell Level

14:50 - 15:20

Solution Providers Presentation

15:20 - 15:50

Evening Refreshments and Poster Presentation | One-to-One Networking

15:50 - 16:30

Single-cell Whole Genome Sequencing to study Somatic CNVs in Human Post-Mortem Brains

Ester Kalef-Ezra

Ester Kalef-Ezra, Postdoctoral Research Fellow, Proukakis Lab, University College London

16:30 - 17:00

Cancer biomarker discovery

17:00 - 17:30

Application of multiplex imaging – Single cell and tissue imaging

17:30 - 18:00

Closing Remarks from the Chairperson

18:00 - 18:00

Drinks Reception and Networking

18:00 - 18:00

End of Day 1

18:00 - 18:00

Registration

08:15 - 08:50

Welcome note by MarketsandMarkets

08:50 - 08:55

Opening remarks by the Chairperson

08:55 - 09:00

Emerging tools and Technologies in Single Cell Omics

Changing Research in Omics Data

Alessandro Riccombeni

Alessandro Riccombeni, National Genomics Officer, Microsoft

09:00 - 09:30

Application of Analytical Technologies in Single cell profiling

09:30 - 10:00

Solution Providers Presentation

10:00 - 10:30

Morning Refreshments and Poster Presentation | One-to-One Networking

10:30 - 11:15

Sample preparation and and Processing of Single Cell

11:15 - 11:45

Application of Nanotechnology in Single Cell Analysis

11:45 - 12:15

Single Cell Omics - Role of Microfluidics

12:15 - 12:45

Solution Providers Presentation

12:45 - 13:15

Lunch and Poster Presentation | One-to-One Networking

13:15 - 14:15

New Avenues in Single Cell Omics

14:15 - 14:45

Single Cell Research with Spatial Multiomics Application

14:45 - 15:15

Closing remarks by the Chairperson

15:15 - 15:15

End of Conference

15:15 - 15:15

SPEAKERS

Emmanouil Karteris

Emmanouil Karteris

Reader in Biomedical Sciences, Brunel University

Steven Johnstone

Steven Johnstone

Field Applications Scientist, EMEA FAS, Bio-Techne

Nik Matthews

Nik Matthews

Head of the Imperial BRC Genomics Facility, Imperial College London

Stephen Evans

Stephen Evans

Professor, University of Leeds

Shefali Thakur

Shefali Thakur

Higher Scientific Officer, The Institute of Cancer Research

Susan Heavey

Susan Heavey

Lecturer, University College of London

Danish Memon

Danish Memon

Lead Bioinformatics Scientist, ThirtyFiveBio

Michal Bonar

Michal Bonar

Distribution Support Manager EMEA, Nanocellect

Alain Wagner

Alain Wagner

Co-founder, MicroOmiX Tech

Viktor Lukacs

Viktor Lukacs

Assistant Professor, University of Leeds

Alessandro Riccombeni

Alessandro Riccombeni

National Genomics Officer, Microsoft

Senior Representative, Adaptimmune Therapeutics Plc

Senior Representative, Adaptimmune Therapeutics Plc

Senior Representative, Adaptimmune Therapeutics Plc

Dimitrios A. Lamprou

Dimitrios A. Lamprou

Professor (chair) of Biofabrication and Advanced Manufacturing, Queen’s University Belfast

Rick Kamps

Rick Kamps

Head Research Engineer in the Department of Toxicogenomics, Maastricht University

Ester Kalef-Ezra

Ester Kalef-Ezra

Postdoctoral Research Fellow, Proukakis Lab, University College London

ENQUIRE NOW

SPONSORS

Proteome Sciences
Swift Analytical
Bio-Techne
Source Genomics
Levitas Bio
NanoCellect

PARTNERS

LOCATION

Venue

Ibis London Earls Court Hotel & ILEC Conference Centre

PAST EVENT GALLERY